Sign In
Last checked at 
7 Aug 2020 14:20
VALIRX PLC
("ValiRx", the "Company" or the "Group")
Director Dealing
London, UK 7 August 2020: ValiRx Plc (AIM: VAL), the clinical stage biotechnology company announces the following dealing in the ordinary shares of the Company made by a Director.
On 7 August 2020, the Company was informed that Dr Kevin Cox, Non-executive Chairman of the Company, acquired 117,000 ValiRx ordinary shares at an average price of 8.2 pence per share on 7 August 2020, representing approximately 0.22% of the Company's issued ordinary share capital. Following this acquisition, Dr Cox now holds an interest in 250,333 ValiRx ordinary shares, representing approximately 0.46% of the Company's issued ordinary share capital.
This announcement contains inside information for the purposes of Article 7 of EU Regulation 596/2014.
For further information please contact:
|
| ||||||||
|
| ||||||||
|
|
Notification of a Transaction pursuant to Article 19(1) of Regulation (EU) No. 596/2014 | ||||||||||
1 | Details of the person discharging managerial responsibilities/person closely associated | |||||||||
a. | Name | Dr Kevin Cox | ||||||||
2 | Reason for notification |
| ||||||||
a. | Position/Status | Non-executive Chairman | ||||||||
b. | Initial notification/ Amendment | Initial | ||||||||
3 | Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor | |||||||||
a. | Name | ValiRx PLC | ||||||||
b. | LEI |
| ||||||||
4 | Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted | |||||||||
a. | Description of the financial instrument, type of instrumentIdentification Code | Ordinary Shares
ISIN: GB00BLH13C52 | ||||||||
b. | Nature of the transaction | On market Purchase | ||||||||
c. | Price(s) and volume(s) |
|
|
|
|
| ||||
| Price(s) | Volume(s) |
| |||||||
8.2 pence
| 117,000 |
| ||||||||
| ||||||||||
d. | Aggregated information - Aggregated Volume - Price |
N/A
| ||||||||
e. | Date of the transaction | 07/08/2020 | ||||||||
f. | Place of the transaction | London, UK
| ||||||||
Follow the stocks
